Search alternatives:
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a non » _ non (Expand Search)
-
501
-
502
-
503
Participant characteristics (non-weighted).
Published 2024“…Differences were noted between the models of only males and only females. Decreased walking endurance is associated with a decreased likelihood of walking in the community—a factor that can be addressed by rehabilitation professionals and in community based programs.…”
-
504
Proliferation defects in Opa1 depleted type II NB lineages are suppressed by overexpression of Drp1<sup>SD</sup>.
Published 2022“…Quantification of EdU positive cells in type II NB lineages (F) in <i>pnt</i>-Gal4, mCD8-GFP +/+ (35 Type II NB lineages, 6 Brains), Drp1<sup>SD</sup> (21,7), <i>opa1</i> RNAi (26,6), Drp1<sup>SD</sup>;<i>opa1</i> RNAi (23,7), <i>marf</i> RNAi (29,7), Drp1<sup>SD</sup>;<i>marf</i> RNAi (14,5). Statistical analysis was done by using unpaired t-test.ns- non-significant, **- p<0.01, ***- p<0.001.…”
-
505
Drp1<sup>SD</sup> overexpression in Opa1 or Marf depleted type II NBs rescues the reduced mitochondrial membrane potential.
Published 2022“…<p>A, B: Representative images showing decreased TMRM intensity in <i>opa1</i> RNAi and <i>marf</i> RNAi expressing type II NBs. …”
-
506
-
507
-
508
-
509
-
510
-
511
-
512
-
513
Flow chart of the expression-based functional screen, with validation steps.
Published 2022Subjects: -
514
-
515
-
516
-
517
-
518
-
519
Lithium Decreases Glial Fibrillary Acidic Protein in a Mouse Model of Alexander Disease
Published 2015“…Here we tested whether lithium treatment would decrease levels of GFAP in a mouse model of Alexander disease. …”
-
520